Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants

• Published in: Biopharmaceutics & drug disposition 2013-03, Vol.34 (2), p.87-97
• Main Authors: Uno, Tomohide, Obe, Yuichiro, Ogura, Chika, Goto, Tatsushi, Yamamoto, Kohei, Nakamura, Masahiko, Kanamaru, Kengo, Yamagata, Hiroshi, Imaishi, Hiromasa
• Format: Article
• Language: English
• Subjects: Aryl Hydrocarbon Hydroxylases - genetics; Aryl Hydrocarbon Hydroxylases - metabolism; Biological and medical sciences; Coumarins - metabolism; Cytochrome P-450 CYP2A6; Escherichia coli - genetics; flavanone; Flavanones - metabolism; General pharmacology; Genetic Variation; HPLC; Humans; Hydroxylation; Medical sciences; monooxygenase; NADPH-Ferrihemoprotein Reductase - genetics; NADPH-Ferrihemoprotein Reductase - metabolism; P450; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions; Pharmacology. Drug treatments; polymorphism; Recombinant Proteins - genetics; Recombinant Proteins - metabolism; Safrole - metabolism
• ISSN: 0142-2782; 1099-081X
• DOI: 10.1002/bdd.1825

ABSTRACT CYP 2A6 is a human enzyme that metabolizes many xenobiotics including coumarin, indole, nicotine and carcinogenic nitrosamines. The gene for CYP2A6 is polymorphic. There are few data available to clarify the relationship between P450 genetic variants and the metabolism of materials in food. The CYP 2A6 wild‐type protein and 13 mutants (CYP2A6.1, CYP2A6.2, CYP2A6.5, CYP2A6.6, CYP2A6.7, CYP2A6.8, CYP2A6.11, CYP2A6.15, CYP2A6.16, CYP2A6.17, CYP2A6.18, CYP2A6.21, CYP2A6.23 and CYP2A6.25) were co‐expressed with NADPH‐cytochrome P450 reductase in E. coli. The hydroxylase activities toward 7‐ethoxycoumarin, coumarin, safrole, flavanone and hydroxyflavanone were examined. Ten types of CYP2A6 variants except for CYP2A6.2, CYP2A6.5 and CYP2A6.6 showed Soret peaks (450 nm) typical of P450 in the reduced CO‐difference spectra and had 7‐ethoxycoumarin O‐deethylase activities. CYP2A6.15 and CYP2A6.18 showed higher activities for safrole 1′‐hydroxylation than CYP2A6.1. CYP2A6.25 and CYP2A6.7 had lower safrole 1′‐hydroxylase activities. CYP2A6.7 had lower flavanone 6‐ and 2′‐hydroxylase activities, whereas CYP2A6.25 had higher 6‐hydroxylase activity and lower 2′‐hydroxylase activity. Hydroxyflavanone was metabolized by CYP2A6.25, but was not metabolized by wild‐type CYP2A6.1. These results indicate that CYP2A6.25 possessed new substrate specificity toward flavonoids. Copyright © 2012 John Wiley & Sons, Ltd.